Thus, hypoxia and activity of IGF-I are two parallel paths for the induction of HIF-1 in cancer [73], and the expression of HIF-1α and vascular endothelial growth factor (VEGF) in CRC tissues was proposed to serve as a biomarker of cancer progression [185]. The gene discussed is IGF1; the disease is cancer.